X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (27903) 27903
Newsletter (706) 706
Magazine Article (84) 84
Book Chapter (80) 80
Newspaper Article (65) 65
Dissertation (29) 29
Publication (14) 14
Web Resource (14) 14
Journal / eJournal (13) 13
Conference Proceeding (5) 5
Book Review (4) 4
Book / eBook (2) 2
Report (2) 2
Streaming Video (2) 2
Government Document (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (16867) 16867
amphotericin b (8474) 8474
male (8375) 8375
amphotericin b - therapeutic use (8186) 8186
index medicus (7387) 7387
amphotericin-b (7112) 7112
female (6650) 6650
antifungal agents - therapeutic use (6232) 6232
microbiology (5174) 5174
adult (5163) 5163
animals (4815) 4815
middle aged (4525) 4525
infectious diseases (4349) 4349
pharmacology & pharmacy (4255) 4255
amphotericin b - pharmacology (3980) 3980
antifungal agents - pharmacology (3803) 3803
amphotericin b - administration & dosage (3397) 3397
fluconazole (3078) 3078
microbial sensitivity tests (2636) 2636
aged (2621) 2621
antiparasitic agents (2619) 2619
voriconazole (2525) 2525
antifungal agents - administration & dosage (2359) 2359
candidiasis - drug therapy (2316) 2316
antifungal agents (2216) 2216
treatment outcome (2147) 2147
mycoses - drug therapy (2092) 2092
adolescent (2049) 2049
infections (2035) 2035
mycology (2022) 2022
immunology (1978) 1978
mice (1973) 1973
itraconazole (1961) 1961
child (1832) 1832
liposomal amphotericin-b (1824) 1824
aspergillosis - drug therapy (1619) 1619
aspergillosis (1603) 1603
therapy (1590) 1590
fungal-infections (1544) 1544
health aspects (1532) 1532
drug therapy, combination (1530) 1530
mycoses (1520) 1520
infection (1502) 1502
diagnosis (1403) 1403
research (1365) 1365
epidemiology (1316) 1316
amphotericin b - adverse effects (1307) 1307
in-vitro (1298) 1298
immunocompromised host (1271) 1271
candida - drug effects (1264) 1264
risk factors (1240) 1240
fluconazole - therapeutic use (1229) 1229
caspofungin (1224) 1224
medicine, general & internal (1217) 1217
care and treatment (1213) 1213
liposomes (1213) 1213
candida albicans - drug effects (1177) 1177
candidiasis (1161) 1161
fungi (1119) 1119
analysis (1118) 1118
child, preschool (1069) 1069
fungal infections (1058) 1058
retrospective studies (1054) 1054
susceptibility (1049) 1049
antifungal agents - adverse effects (1030) 1030
drug therapy (1023) 1023
candida (1017) 1017
transplantation (999) 999
invasive aspergillosis (995) 995
candidiasis - microbiology (982) 982
efficacy (961) 961
resistance (951) 951
visceral leishmaniasis (931) 931
candida-albicans (921) 921
research article (915) 915
triazoles - therapeutic use (912) 912
fluconazole - pharmacology (910) 910
flucytosine - therapeutic use (905) 905
toxicity (903) 903
pharmacokinetics (899) 899
mortality (898) 898
drugs (897) 897
echinocandins (888) 888
infant (884) 884
cryptococcosis - drug therapy (863) 863
mucormycosis (856) 856
aspergillus (843) 843
lung diseases, fungal - drug therapy (841) 841
drug resistance, fungal (840) 840
leishmaniasis, visceral - drug therapy (834) 834
candida albicans (831) 831
surgery (831) 831
biochemistry & molecular biology (830) 830
time factors (826) 826
meningitis (815) 815
oncology (808) 808
pediatrics (803) 803
dose-response relationship, drug (785) 785
dermatology (774) 774
antifungals (770) 770
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (25829) 25829
French (858) 858
Spanish (614) 614
German (538) 538
Japanese (429) 429
Russian (258) 258
Portuguese (153) 153
Italian (127) 127
Chinese (108) 108
Turkish (66) 66
Polish (47) 47
Korean (41) 41
Dutch (32) 32
Czech (23) 23
Danish (16) 16
Hungarian (14) 14
Norwegian (13) 13
Persian (12) 12
Hebrew (9) 9
Romanian (6) 6
Swedish (6) 6
Finnish (4) 4
Serbian (3) 3
Ukrainian (3) 3
Croatian (2) 2
Lithuanian (2) 2
Slovak (2) 2
Afrikaans (1) 1
Bulgarian (1) 1
Indonesian (1) 1
Slovenian (1) 1
Thai (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 7/2010, Volume 51, Issue 2, pp. 225 - 232
Journal Article
Journal Article
International Journal of Nanomedicine, ISSN 1176-9114, 11/2014, Volume 9, Issue 1, pp. 5403 - 5413
Background: Amphotericin B (AMB) is a polyene antibiotic with broad spectrum antifungal activity, but its clinical toxicities and poor solubility limit the wide application of AMB in clinical practice... 
Drug delivery | Nanocarrier | Anti-infection | Amphotericin B | C. albicans | APOPTOSIS | anti-infection | nanocarrier | NANOSCIENCE & NANOTECHNOLOGY | PHARMACOLOGY & PHARMACY | drug delivery | amphotericin B | COPOLYMER | FUNGAL-INFECTIONS | Nanoparticles - chemistry | Liver - microbiology | Vitamin E - analogs & derivatives | Drug Carriers - toxicity | Polyethylene Glycols - chemistry | Antifungal Agents - chemistry | Colony Count, Microbial | Candidiasis - microbiology | Amphotericin B - toxicity | Drug Carriers - chemistry | Candida albicans - drug effects | Antifungal Agents - pharmacokinetics | Ethylene Glycols - chemistry | Amphotericin B - pharmacokinetics | Vitamin E - chemistry | Amphotericin B - chemistry | Antifungal Agents - toxicity | Antifungal Agents - pharmacology | Amphotericin B - pharmacology | Polyethylene Glycols - toxicity | Nanoparticles - toxicity | Polyesters - toxicity | Kidney - microbiology | Polyesters - chemistry | Animals | Vitamin E - toxicity | Mice | Ethylene Glycols - toxicity | Nanoparticles | Complications and side effects | Usage | Antifungal agents | Physiological aspects | Dosage and administration | Research | Properties | Polyols | Drugs | Drug delivery systems | Laboratories | Lipids | Fungal infections | Tropical diseases | Microscopy | Polyethylene glycol | Efficiency | Morphology | Biocompatibility | Apoptosis
Journal Article
The Pediatric Infectious Disease Journal, ISSN 0891-3668, 09/2008, Volume 27, Issue 9, pp. 820 - 826
...) with liposomal amphotericin B (3 mg/kg) as first-line treatment of invasive candidiasis. Treatment success was defined as clinical and mycologic response at the end of therapy... 
Invasive candidiasis | Micafungin | Double-blind trial | Pediatric | INFECTIOUS DISEASES | ECHINOCANDIN